1Francis DP, Hadler SC,Thompson SE,et al. The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men[J]. Ann Intern Med, 1982,97(3):362
2Stevens CE, Taylor PE, Tong MJ, et al. Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hapatitis B virus transmission[J]. JAMA,1987,257(19):2612
3Kane MA. Global status of hepatitis B immunisation[J].Lancet, 1996,348(9029) :696
4Szmuness W, Stevens CE, Zang EA, et al. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B) :a final report[J]. Hepatology, 1981,1(5):377
5Michel ML,Davis HL, Schleef M, et al. DNA-mediated immunization to the hepatitis B surface antigen in mice:aspecta of humoral response mimic hepatitis B viral infection in humans[J]. Proc Natl Acad Sci USA, 1991,92(12):5307
6Burgess MA, Rodger AJ, Waite SA, et al. Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunterrs: an open, randomised study[J]. Vaccine, 2001,19:4835
7Wagstaff AJ,Balfour JA. Combination hepatitis A-hepatitis B vaccine[J]. Biodrugs, 1997,8:235
8Szmuness W, Stevens CE, Harley EJ, et al. Hepatitis B vaccine in medical staff of hemodialysis units:efficacy and subtype cross-protection [J]. N Engl J Med, 1982, 307(24): 1481
9Arbuthnot P,Kew M. Hepatitis B Virus and hepatocellular carcinoma[J]. Int J Exp Pathol, 2001,82 (2): 77
10Davis HL, McCluskie MJ, Gerin JL, et al. DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines [J]. Proc Natl Acad Sci USA, 1996,93:7213
